Stocks · Health care · Biological Products, (No Diagnostic Substances)

Allogene Therapeutics, Inc.

ALLO Clue Score24
United States Fiscal year ends December CIK 0001737287 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Deborah M. Messemer
10 Jun 2025
Director
Sold on a plan
36,885
$1.42
$52.38K
Deborah M. Messemer
18 Feb 2025
Director
Sold on a plan
13,313
$2.43
$32.35K
Deborah M. Messemer
9 Dec 2024
Director
Sold on a plan
9,136
$2.18
$19.92K
Deborah M. Messemer
18 Jun 2024
Director
Sold on a plan
18,641
$2.28
$42.49K
Deborah M. Messemer
18 Dec 2023
Director
Sold on a plan
18,640
$2.70
$50.32K

What was left out

Form 4 filings counted 244
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 32
Sales at will 98
Transactions with no price 0
Shares from compensation/vesting 102,298,948
Sales filed before the plan box existed 70
History held since 17 Oct 2018